Ironwood Pharmaceuticals IRWD Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's change in other liabilities?
- Ironwood Pharmaceuticals (IRWD) reported change in other liabilities of -$219K in Q1 2026.
- How has Ironwood Pharmaceuticals's change in other liabilities changed year-over-year?
- Ironwood Pharmaceuticals's change in other liabilities decreased by 217.1% year-over-year, from $187K to -$219K.
- What is the long-term trend for Ironwood Pharmaceuticals's change in other liabilities?
- Over 3 years (2021 to 2025), Ironwood Pharmaceuticals's change in other liabilities has grown at a 43.8% compound annual growth rate (CAGR), from -$1.38M to $4.11M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.